80th scientific sessions of the American Diabetes Association

Valbiotis to present Phase II clinical results of TOTUM•63 in prediabetes at the 2020 scientific sessions of the American Diabetes Association, June 12-16 (in virtual format, due to the COVID-19 health crisis).